Supplementary materials and methods
Differentiation into iPSC-derived hepatocyte-like cells and liver spheroids
B treatment was performed two days after seeding. After 24 h, only supplement B was added for three 35 days, as described in the instructions. The cell layer was then treated for five days with 1 % dimethyl 36 sulfoxide in KO/DMEM (Thermo Fisher Scientific), 20 % KnockOut™ serum replacement (KSR) 37 (Thermo Fisher Scientific), 1 mM glutamine, 1 % nonessential amino acids, 0.1 mM 2-mercaptoethanol 38 (Thermo Fisher Scientific) and 1 % P/S. Due to pronounced cell death during the first two days of the 39 dimethyl sulfoxide treatment, the cells were gently washed with PBS before the medium was replaced. 40
Afterwards, the cell layer was treated for an additional five days with HZM medium (HepatoZYME-41 SFM (Thermo Fisher Scientific) medium with 1 mM nonessential amino acids, 2 mM L-glutamine, 2 % 42 KSR, 10 ng/mL human HGF (Miltenyi), 10 ng/mL human FGF-4 (Peprotech), 10 ng/mL human 43 oncostatin M (Miltenyi), 0.1 µM dexamethason (Ehrenstorfer GmbH) and 1 % P/S). Gentle medium 44 exchange was performed every other day. Liver spheroids were formed by combining iPSC-derived 45 hepatocyte-like cells and iPSC-derived stromal cells using Corning® 384-well spheroid microplate. The 46 iPSC-derived hepatocyte-like cells and iPSC-derived stromal cells were detached with trypsin, 47 centrifuged and diluted in HZM medium (described previously) supplemented with 10 µM Rock 48
Inhibitor and 5 % bovine serum albumin fraction V, fatty acid free (BSA-FAF) (SERVA). A 50 μL cell 49 suspension containing 4.8 × 10 4 hepatocyte-like cells and 0.2 × 10 4 iPSC-derived stromal cells was 50 pipetted into each access hole with a 96-well pipette (Platemaster®, Gilson). After two days of culture 51 on an orbital shaker (Corning), the spheroids were transferred with wide-bore tips to ultra-low 52 attachment 24-well plates. Twenty spheroids were collected together to form a single liver spheroids in 53 the respective culture compartment of the four-organ-chip. (TeSR™-E8™ Optimized), as described above. Following the DE stage, the cell layer was treated with 59 hindgut medium (Advanced DMEM/F-12; Thermo Fisher Scientific) with 50 ng/mL KGF (Peprotech), 60 0.1 % BSA-FAF, 15 mM HEPES, 1x B27-Supplement (Thermo Fisher Scientific) and 1 % P/S for four 61 days. The hindgut medium was added with 50 ng/mL KGF, 2 % BSA-FAF, 15 mM HEPES, 1x B27-62 Supplement, 1 % P/S, 1x insulin-transferrin-selenium (ITS), 200 mg/L, ethanolamin (Sigma) and 2 µM 63 retinoic acid (Alfa Aesar) for the following three days. Subsequently, the 3D cell layer was scraped off 64 with a pipette tip and small pieces were transferred with a cooled wide-bore pipette tip into cool 100 % 65
Differentiation into iPSC-derived intestinal organoids and cell culture insert®
Matrigel (354234). The suspension was mixed gently without producing bubbles and 50 µL Matrigel 66 cell suspension was transferred immediately with a cooled wide-bore pipette tip into the middle of a 67 37 °C pre-warmed 24-well plate. The Matrigel was solidified in the incubator for 10 min, then 500 µL 68 intestinal medium (Advanced DMEM/F-12 with 2 mM L-glutamine, 15 mM HEPES, 1x 69 B27-supplement, 1 % P/S, 500 ng/mL R-Spondin-1 (Peprotech), 100 ng/mL Noggin (Peprotech) and 70 100 ng/mL EGF (StemCell) was added. Intestinal organoids were passaged every two weeks by 71 resuspending the organoids 10x with a 200 µL pipette in PBS, centrifuging at 300 g at 4 °C for 3 min 72 and transferring the organoids in Matrigel, as described above. Expansion of organoids was increased 73 stepwise from 1:2 to 1:20. The intestinal medium was changed every two to three days. For the intestinal 74 model cell culture insert (Millicell PCF 0.4 µm pores PIHP01250) 0.6 x 10 6 iPSC-derived stromal cells 75 per cell culture insert were seeded in stromal cell medium. After two days, the cell culture inserts were 76 washed gently with PBS, 50 µL cooled Matrigel was added and the intestinal organoids in passage six 77
were seeded on top of the stromal cells in 70 µL Matrigel-medium (50/50) suspension. One Matrigel 78 organoid 24-well droplet was used for two cell culture inserts. After the Matrigel solidified, 100 µL 79 intestinal medium was added into the cell culture insert and 500 µL underneath. Intestinal medium was 80 changed every two to three days. The intestinal models on cell culture inserts were cultivated for two 81 weeks before transferring them into the four-organ-chip for further co-culture.
Differentiation into iPSC-derived renal cells 83
Renal cell differentiation was carried out with modifications from Morizane and Bonventre [5] . The 84 iPSCs were grown until 50 % confluent. Subsequently, the cells were washed gently with PBS and the 85 medium was replaced by advanced RPMI 1640 (Thermo Fisher Scientific) with 2 mM L-glutamine, 86 5 µg/mL gentamycin sulfate and 0.25 µg/mL amphotericin B (renal basal medium). 8 µM CHIR99021 87 (LC Labs) was added to the medium during the first four days. Medium was replaced every other day. 88
Afterwards, the renal basal medium was added with 10 ng/mL Activin A (Peprotech) for three days 89 without medium exchange. The cells were then washed with PBS and 10 ng/mL FGF-9 (Peprotech) was 90 added to the renal basal medium. Two days later, an induction with 3 µM CHIR99021 and 10 ng/mL 91 FGF-9 was carried out. Subsequently, the cells were detached using Accutase and about 10 6 cells were 92 injected gently into the excretory circuit of each four-organ-chip. The excretory circuit was coated 93 previously with 1 % GFR Matrigel and filled with renal basal medium supplemented with 10 ng/mL 94 FGF-9. Two days later, 50 % renal basal medium supplemented with 10 ng/mL FGF-9 was replaced in 95 the chip. Renal cells were injected six days before the start of the four-organ-chip co-culture. 96
Differentiation into iPSC-derived cortical neurospheres and Transwell® seeding 97
Differentiation of iPSCs into cortical progenitor cell spheroids, referred to as neurospheres, was 98 performed in a DASbox® Mini Bioreactor System (Eppendorf) [6] . The culture protocol was adapted 99 from Rigamonti et al. [7] . Initial spheroid formation of iPSCs in the DASbox bioreactor was performed 100 as described by Abecasis et al. [8] . The iPSCs were inoculated as a single cell suspension with a 101 concentration of 2.5 x 10 5 cells/mL in 125 mL StemMACS iPS-Brew XF supplemented with 10 µM 102
Rock Inhibitor Y-27632 in a 250-mL fermentation vessel (DASbox Mini Bioreactor System). The vessel 103 was equipped with a trapezoid-shaped impeller, a submerged tube for media withdrawal, a non-104 submerged tube for media feeding, and a dissolved oxygen and pH sensor. Sensors and pumps were 105 calibrated according to the manufacturer's protocols. The submerged sampling tube was equipped with 106 a 10 µm porous filter to allow the washout of single cells while retaining the iPSC spheroids in the 107 vessel. The vessel was kept at a temperature of 37 °C and aerated with 3 sl/hour (5 % CO2, variable O2) 108 and a stirrer speed of 80 rpm. The aeration with oxygen was adjusted automatically by DASware control 109 software (Eppendorf) to achieve a stable oxygen saturation at 19 % dissolved oxygen. No medium wasexchanged for the first 24 h after inoculation. Starting at day two, medium was exchanged via the tubing 111 system at a rate of 120 mL/day at day two, 60 mL/day at day three, 90 mL/day at day four and 112 120 mL/day at day five. After five days of cultivation, the process was stopped temporarily, and the 113 spheroids were used for cortical differentiation. Agitation was stopped and the spheroids were allowed 114 to settle at the bottom of the vessel. The culture medium was removed completely and the spheroids 115 suspended in a defined volume of fresh iPSC culture medium. The suspension was mixed well and a 116 sample was taken for cell counting with an automated cell counter (Nucleocounter NC-200, 117
Chemometec). Cells were reintroduced as spheroids into the DASbox bioreactor system with 7.5 x 10 5 118 cells/mL in 100 mL StemMACS iPS-Brew XF. The system was operated with the same process 119 parameters, as described for the spheroid formation. After 24 h (day two of differentiation), the medium 120 was completely exchanged manually with KSR medium (KO-DMEM (Thermo Fisher Scientific) with 121 15 % KSR, 1 % nonessential amino acids, 2 mM L-Glutamine, 1 % P/S and 50 µM 2-mercaptoethanol). 122
The medium was constantly exchanged at a rate of 2.08 mL/h from day two on. Only KSR medium was 123 fed until day 4. From then on to day 10, the KSR medium was gradually diluted with neural induction 124 medium (DMEM/F12 (Thermo Fisher Scientific) with 1 % N2 (Thermo Fisher Scientific), 2 % B27 125 without vitamin A (Thermo Fisher Scientific), 1 % nonessential amino acids, 2 mM L-Glutamine and 126 1 % P/S. Only neural induction medium was fed from day 10 to day 30. The cell culture medium was 127 supplemented with 10 µM SB431542 (Miltenyi) and 1 µM LDN193189 (Sellekchem) from day one to 128 day seven. From day two to four, medium was furthermore supplemented with 2 µM XAV939 129 (Cayman). After 30 days, neurospheres were collected and cell debris was removed with a 37 µm 130 reversible strainer (Stemcell). The spheroids were resuspended in a defined volume of neural cultivation 131 medium (Neurobasal (Thermo Fisher Scientific) with 1 % N2, 2% B27 without vitamin A, 1% 132 nonessential amino acids, 2 mM L-glutamine and 1 % P/S. The suspension was mixed well and a sample 133 was taken for cell counting. The neurospheres were further cultivated in neural cultivation medium in 134 an Erlenmeyer flask on an orbital shaker. The next day, the neurospheres were transferred into a 96-well 135
Transwell® system with a 1 µm pore polyester membrane (Corning). A total of 2 x 10 6 cells was 136 transferred into each Transwell. Spheroids were cultured for 24 h in neural cultivation medium before 137 individual Transwells were transferred into the microfluidic chip system.
Analysis

139
Characterization of fluid dynamics in the four-organ-chip 140
The two integrated peristaltic micropumps generated the flow in both microfluidic circuits. Their 141 working principle is explained elsewhere [9] . The deflection of the pumps' membranes was controlled 142
by an external unit (TissUse GmbH) that managed the frequency of deflection, pressure and vacuum. 143
Their interplay defined the flow rate within the two circuits. Micro particle image velocimetry (µPIV) 144 was applied to determine the flow rate for the set process parameters. Red blood cells were utilized to 145 visualize the flow. Therefore, red blood cells were suspended in PBS at a hematocrit of 2.5 %. The µPIV 146 analyses were carried out in straight channels. Throughout the measurements, the chip was equipped 147 
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